CLINICAL_TRIALS
ClinicalTrials.gov record update
Dose-attenuated IST and Hetrombopag in the Treatment of Elderly (≥65 Years) Patients With Very Severe/Severe Aplastic Anemia: A Single-Center, Single-Arm, Phase IIB Clinical Study on Efficacy and Safety
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT07010237
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:42.686301+00:00
- Published At
- 2025-06-08T00:00:00+00:00
- Record Updated At
- 2025-06-08
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Sever Aplastic Anaemia", "Elderly (People Aged 65 or More)", "Immunosuppressive Treatment"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-06-08"- protocolSection.identificationModule.nctId
"NCT07010237"- protocolSection.identificationModule.officialTitle
"Dose-attenuated IST and Hetrombopag in the Treatment of Elderly (\u226565 Years) Patients With Very Severe/Severe Aplastic Anemia: A Single-Center, Single-Arm, Phase IIB Clinical Study on Efficacy and Safety"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.